733
edits
No edit summary |
|||
Line 17: | Line 17: | ||
* Syncope, documented VT and structural heart disease. IB <cite>ESCsyncope</cite> | * Syncope, documented VT and structural heart disease. IB <cite>ESCsyncope</cite> | ||
* When monomorphic VT is induced at EP study in patients with previous myocardial infarction and syncope. IB <cite>ESCsyncope</cite> | * When monomorphic VT is induced at EP study in patients with previous myocardial infarction and syncope. IB <cite>ESCsyncope</cite> | ||
* HCM with high risk (>5% in 5y): http://doc2do.com/hcm/webHCM.html <cite>ESCHCM</cite> | |||
==Class IIa (should be considered)== | ==Class IIa (should be considered)== | ||
Line 52: | Line 53: | ||
#ESCsyncope pmid=19713422 | #ESCsyncope pmid=19713422 | ||
#ESCfocusedup pmid=20801924 | #ESCfocusedup pmid=20801924 | ||
#ESCHCM pmid=25173338 | |||
</biblio> | </biblio> |